Parallel regulation of oligodendrocyte differentiation by ERK signaling pathway and DNMT3A via NKX6.2 in offspring of advanced maternal age

The brain is a vast network of wires, and for those wires to transmit signals quickly and accurately, they must be wrapped in a protective, fatty coating called myelin. Think of this coating as the insulation on an electrical wire; without it, the signal slows down or gets lost entirely. This insulation is produced by specialized cells called oligodendrocytes, which grow up from precursor cells during early development. When this process goes wrong, the result can be significant problems with movement, learning, and memory. Scientists have long known that offspring born to older mothers face a higher risk of neurodevelopmental issues, and recent work suggests that the quality of this myelin insulation might be a key factor. However, the specific molecular switches that control how these cells mature in the brains of offspring from older mothers have remained a mystery.

A team of researchers at the Children's Hospital of Chongqing Medical University has now peeled back the layers of this mystery, focusing on the brains of rats born to older mothers. They discovered that the problem is not a single broken switch, but rather a complex, two-part failure involving two distinct biological pathways that usually work together to ensure the myelin insulation is built correctly. The study reveals that in these offspring, the cells responsible for making myelin get confused about when to grow and when to mature, leading to a brain that is under-insulated and less capable of handling complex tasks.

The researchers began by observing the behavior of the young rats. Those born to older mothers showed clear signs of struggle. When placed on a rotating rod, they fell off much sooner than their peers born to younger mothers, indicating poor coordination. In a test designed to measure memory and learning, where the rats had to find a hidden platform in a pool of water, the older-mother offspring took longer to learn the location and forgot it faster once the platform was removed. Crucially, their basic muscle strength was normal; they could grip a wire just as well as the others. The issue was not in their muscles, but in how their brains coordinated movement and stored information.

To understand the root cause, the team looked inside the corpus callosum, a thick bundle of nerve fibers that connects the two halves of the brain and is heavily reliant on myelin. Using advanced sequencing to read the genetic instructions within these tissues, they found that the genes responsible for building myelin were turned down. Specifically, the instructions for a key protein called NKX6.2, which acts as a master regulator for the cells that make myelin, were significantly reduced. Without enough of this regulator, the precursor cells failed to mature into the fully functional cells needed to wrap the nerve fibers.

The scientists then moved the experiment to a petri dish, growing these precursor cells in the lab to watch them develop in real time. They observed a strange, two-stage error in the cells from the older-mother offspring. During the first stage, when the cells were supposed to multiply and increase their numbers, a specific signaling pathway known as ERK was too quiet. This pathway is like a gas pedal for cell growth; when it is too weak, the cells do not multiply enough. However, in the second stage, when the cells were supposed to stop growing and start building myelin, that same ERK pathway was stuck in the "on" position, revving too high. This hyperactivity prevented the cells from maturing properly.

Simultaneously, the researchers found another problem that was independent of the first. A molecule called DNMT3A, which acts like a chemical tag that can silence genes, was present in excessive amounts during the maturation stage. This molecule was effectively putting a lock on the genes needed to build myelin, preventing the cells from turning them on. The team had initially suspected that the overactive ERK pathway was causing the DNMT3A molecule to rise, creating a single chain of errors. However, when they blocked the ERK pathway to fix the first problem, the levels of DNMT3A did not change. This proved that the two issues were running on parallel tracks, both converging on the same goal: suppressing the NKX6.2 regulator.

To test if they could fix these errors, the researchers applied targeted treatments. In the lab, they used a drug to quiet the overactive ERK pathway during the maturation stage, and they used a genetic tool to reduce the levels of the DNMT3A molecule. Both interventions, working separately, successfully restored the ability of the cells to mature and build myelin. They also restored the levels of the NKX6.2 regulator and the myelin-building proteins.

The team then returned to the living rats to see if these fixes could work in a whole organism. They treated the offspring of older mothers with the drug that quieted the ERK pathway, and in a separate group, they used a virus to deliver a genetic instruction that reduced DNMT3A levels. Both treatments produced remarkable results. The treated rats showed significant improvements in their motor coordination, staying on the rotating rod much longer. Their performance in the water maze also improved; they learned the location of the platform faster and remembered it better. Inside their brains, the levels of the NKX6.2 regulator and myelin proteins had returned to normal, and the cells were successfully wrapping the nerve fibers.

This study provides a clear picture of how advanced maternal age can disrupt brain development. It shows that the risk is not due to a single broken component, but rather a dual failure where two separate biological systems, the ERK signaling pathway and the DNMT3A molecule, both malfunction during the critical window when myelin is being built. These systems act independently but both end up silencing the master regulator needed for the job. The findings suggest that there are multiple potential points of intervention. By targeting either the signaling pathway or the chemical tagging molecule, it might be possible to restore the brain's ability to insulate its wires, offering a new avenue for understanding and potentially treating neurodevelopmental challenges associated with advanced maternal age.